scholarly article | Q13442814 |
P50 | author | Roberto Bolli | Q56166630 |
P2093 | author name string | Kyung U Hong | |
P2860 | cites work | Mixed chimerism of cardiomyocytes and vessels after allogeneic bone marrow and stem-cell transplantation in comparison with cardiac allografts | Q80257370 |
Cellular cardiomyoplasty: improvement of left ventricular function correlates with the release of cardioactive cytokines | Q80264618 | ||
Isolation and expansion of adult cardiac stem cells from human and murine heart | Q80837204 | ||
Improved graft mesenchymal stem cell survival in ischemic heart with a hypoxia-regulated heme oxygenase-1 vector | Q81297170 | ||
Heart Disease and Stroke Statistics--2013 Update: A Report From the American Heart Association | Q22306356 | ||
Structure and organization of the RBMY genes on the human Y chromosome: transposition and amplification of an ancestral autosomal hnRNPG gene | Q24318737 | ||
A Y chromosome gene family with RNA-binding protein homology: candidates for the azoospermia factor AZF controlling human spermatogenesis | Q24323950 | ||
De novo cardiomyocytes from within the activated adult heart after injury | Q24605971 | ||
Mammalian heart renewal by pre-existing cardiomyocytes | Q24632538 | ||
Enhancement of myocardial regeneration through genetic engineering of cardiac progenitor cells expressing Pim-1 kinase | Q24646472 | ||
Cre reporter strains produced by targeted insertion of EYFP and ECFP into the ROSA26 locus | Q24797230 | ||
Cell therapy for heart failure: a comprehensive overview of experimental and clinical studies, current challenges, and future directions | Q27001159 | ||
Cellular survival: a play in three Akts | Q29547806 | ||
Human cardiovascular progenitor cells develop from a KDR+ embryonic-stem-cell-derived population | Q29616533 | ||
Z/EG, a double reporter mouse line that expresses enhanced green fluorescent protein upon Cre-mediated excision | Q29618895 | ||
RETRACTED: Cardiac stem cells in patients with ischaemic cardiomyopathy (SCIPIO): initial results of a randomised phase 1 trial | Q29620044 | ||
Adult cardiac stem cells are multipotent and support myocardial regeneration | Q29620122 | ||
Paracrine mechanisms in adult stem cell signaling and therapy | Q29620571 | ||
Guided cardiopoiesis enhances therapeutic benefit of bone marrow human mesenchymal stem cells in chronic myocardial infarction | Q30496413 | ||
Administration of granulocyte colony-stimulating factor after myocardial infarction enhances the recruitment of hematopoietic stem cell-derived myofibroblasts and contributes to cardiac repair. | Q50670224 | ||
Evidence for ischemia induced host-derived bone marrow cell mobilization into cardiac allografts. | Q51789715 | ||
Survival, integration, and differentiation of cardiomyocyte grafts: a study in normal and injured rat hearts. | Q52175867 | ||
Pilot trial on determinants of progenitor cell recruitment to the infarcted human myocardium. | Q53453905 | ||
Preconditioning mesenchymal stem cells with transforming growth factor-alpha improves mesenchymal stem cell-mediated cardioprotection. | Q54705013 | ||
Diabetes Promotes Cardiac Stem Cell Aging and Heart Failure, Which Are Prevented by Deletion of the p66 shc Gene | Q59485549 | ||
Human mesenchymal stem cells differentiate to a cardiomyocyte phenotype in the adult murine heart | Q64379356 | ||
DNA synthesis by cultured myocardial cells | Q72300039 | ||
Bone marrow-derived cardiomyocytes are present in adult human heart: A study of gender-mismatched bone marrow transplantation patients | Q73106026 | ||
Mesenchymal stem cells modified with Akt prevent remodeling and restore performance of infarcted hearts | Q73791469 | ||
Cardiomyocytes of noncardiac origin in myocardial biopsies of human transplanted hearts | Q74397725 | ||
Cardioselective overexpression of HO-1 prevents I/R-induced cardiac dysfunction and apoptosis | Q74478139 | ||
Chimerism of the transplanted heart | Q77452324 | ||
An infarct-like myocardial lesion and other toxic manifestations produced by isoproterenol in the rat | Q78580776 | ||
Induction of the heme oxygenase-1 gene by metalloporphyrins | Q31424395 | ||
CD31- but Not CD31+ cardiac side population cells exhibit functional cardiomyogenic differentiation | Q33216802 | ||
Cardiac side population cells have a potential to migrate and differentiate into cardiomyocytes in vitro and in vivo | Q33270812 | ||
Stem cells in the dog heart are self-renewing, clonogenic, and multipotent and regenerate infarcted myocardium, improving cardiac function | Q33863225 | ||
Cardiac stem cells delivered intravascularly traverse the vessel barrier, regenerate infarcted myocardium, and improve cardiac function | Q33928468 | ||
c-kit+ cells minimally contribute cardiomyocytes to the heart | Q34021586 | ||
O-GlcNAc signaling in the cardiovascular system | Q34056858 | ||
Molecular imaging of cardiac cell transplantation in living animals using optical bioluminescence and positron emission tomography | Q34134449 | ||
Human cardiac progenitor cells engineered with Pim-I kinase enhance myocardial repair. | Q34290791 | ||
Stem and progenitor cells: origins, phenotypes, lineage commitments, and transdifferentiations | Q34425181 | ||
Paracrine mechanisms of stem cell reparative and regenerative actions in the heart | Q34494230 | ||
The role of the sca-1+/CD31- cardiac progenitor cell population in postinfarction left ventricular remodeling | Q34513743 | ||
Genetic inducible fate mapping in mouse: establishing genetic lineages and defining genetic neuroanatomy in the nervous system | Q34551551 | ||
Protein kinase G1 α overexpression increases stem cell survival and cardiac function after myocardial infarction | Q34639920 | ||
Evidence from a genetic fate-mapping study that stem cells refresh adult mammalian cardiomyocytes after injury | Q34657173 | ||
Stem cell niches in the adult mouse heart | Q34657903 | ||
Cardioprotective c-kit+ cells are from the bone marrow and regulate the myocardial balance of angiogenic cytokines | Q34698821 | ||
Pim-1: a serine/threonine kinase with a role in cell survival, proliferation, differentiation and tumorigenesis. | Q35004096 | ||
Relative roles of direct regeneration versus paracrine effects of human cardiosphere-derived cells transplanted into infarcted mice. | Q35050037 | ||
Formation of human myocardium in the rat heart from human embryonic stem cells | Q35221817 | ||
The epicardium and epicardially derived cells (EPDCs) as cardiac stem cells | Q35618207 | ||
Cardiomyogenesis in the developing heart is regulated by c-kit-positive cardiac stem cells | Q35798731 | ||
Mesenchymal stem cells overexpressing CXCR4 attenuate remodeling of postmyocardial infarction by releasing matrix metalloproteinase-9. | Q35809394 | ||
Human cardiac stem cells | Q35956924 | ||
Administration of cardiac stem cells in patients with ischemic cardiomyopathy: the SCIPIO trial: surgical aspects and interim analysis of myocardial function and viability by magnetic resonance | Q36252910 | ||
The heme oxygenase 1 inducer (CoPP) protects human cardiac stem cells against apoptosis through activation of the extracellular signal-regulated kinase (ERK)/NRF2 signaling pathway and cytokine release | Q36286171 | ||
Increased mitotic rate coincident with transient telomere lengthening resulting from pim-1 overexpression in cardiac progenitor cells. | Q36342079 | ||
Cardiac progenitor cells from adult myocardium: Homing, differentiation, and fusion after infarction | Q36349782 | ||
Life and death of cardiac stem cells: a paradigm shift in cardiac biology | Q36426493 | ||
Enhanced effect of combining human cardiac stem cells and bone marrow mesenchymal stem cells to reduce infarct size and to restore cardiac function after myocardial infarction | Q36630155 | ||
The inflammation hypothesis and its potential relevance to statin therapy | Q36743196 | ||
Intracoronary administration of cardiac stem cells in mice: a new, improved technique for cell therapy in murine models | Q36806912 | ||
Adult cardiac-resident MSC-like stem cells with a proepicardial origin | Q36838490 | ||
Dissecting the molecular relationship among various cardiogenic progenitor cells | Q36853973 | ||
A highly sensitive and accurate method to quantify absolute numbers of c-kit+ cardiac stem cells following transplantation in mice | Q36933345 | ||
Systems approaches to preventing transplanted cell death in cardiac repair. | Q36984663 | ||
Stem-cell therapy for cardiac disease | Q37089732 | ||
Acute preconditioning of cardiac progenitor cells with hydrogen peroxide enhances angiogenic pathways following ischemia-reperfusion injury | Q37111498 | ||
Genetic enhancement of stem cell engraftment, survival, and efficacy | Q37156670 | ||
Strategies to promote donor cell survival: combining preconditioning approach with stem cell transplantation | Q37162061 | ||
Cardiac stem cells and myocardial disease | Q37206379 | ||
Mesenchymal stem cell survival in the infarcted heart is enhanced by lentivirus vector-mediated heat shock protein 27 expression | Q37208393 | ||
Intracoronary delivery of autologous cardiac stem cells improves cardiac function in a porcine model of chronic ischemic cardiomyopathy | Q37253597 | ||
Pharmacologically active microcarriers influence VEGF-A effects on mesenchymal stem cell survival | Q37295351 | ||
Identification of a coronary vascular progenitor cell in the human heart | Q37354199 | ||
Local activation or implantation of cardiac progenitor cells rescues scarred infarcted myocardium improving cardiac function | Q37355668 | ||
Thymosin β4 increases the potency of transplanted mesenchymal stem cells for myocardial repair | Q37457917 | ||
Role of GATA-4 in differentiation and survival of bone marrow mesenchymal stem cells | Q38037184 | ||
Priming with ligands secreted by human stromal progenitor cells promotes grafts of cardiac stem/progenitor cells after myocardial infarction | Q38525084 | ||
Protein O-GlcNAcylation is a novel cytoprotective signal in cardiac stem cells | Q39242509 | ||
Interrelations of the proliferation and differentiation processes during cardiact myogenesis and regeneration | Q39712704 | ||
Engraftment, differentiation, and functional benefits of autologous cardiosphere-derived cells in porcine ischemic cardiomyopathy | Q39864941 | ||
Akt promotes survival of cardiomyocytes in vitro and protects against ischemia-reperfusion injury in mouse heart. | Q39870130 | ||
Gene therapy strategy for long-term myocardial protection using adeno-associated virus-mediated delivery of heme oxygenase gene | Q40662320 | ||
Anthracycline cardiomyopathy is mediated by depletion of the cardiac stem cell pool and is rescued by restoration of progenitor cell function | Q41883542 | ||
Mitosis during postnatal growth in skeletal and cardiac muscle of the rat | Q41894624 | ||
Repair of the injured adult heart involves new myocytes potentially derived from resident cardiac stem cells | Q41964256 | ||
Adult c-kit(pos) cardiac stem cells are necessary and sufficient for functional cardiac regeneration and repair. | Q42250849 | ||
Intracoronary administration of cardiac progenitor cells alleviates left ventricular dysfunction in rats with a 30-day-old infarction | Q42644713 | ||
Mechanism of improved cardiac function after bone marrow mononuclear cell therapy: role of cardiovascular lineage commitment | Q43084897 | ||
Temporally regulated and tissue-specific gene manipulations in the adult and embryonic heart using a tamoxifen-inducible Cre protein | Q43664631 | ||
Overexpression of MicroRNA-1 improves the efficacy of mesenchymal stem cell transplantation after myocardial infarction | Q44415960 | ||
The post-natal heart contains a myocardial stem cell population. | Q45855585 | ||
Identification of a lineage of multipotent hematopoietic progenitors. | Q45969717 | ||
Pim-1 regulates cardiomyocyte survival downstream of Akt. | Q46022665 | ||
Regenerative potential of cardiosphere-derived cells expanded from percutaneous endomyocardial biopsy specimens. | Q48414650 | ||
P275 | copyright license | Creative Commons Attribution 4.0 International | Q20007257 |
P6216 | copyright status | copyrighted | Q50423863 |
P433 | issue | 7 | |
P304 | page(s) | 324 | |
P577 | publication date | 2014-07-01 | |
P1433 | published in | Current treatment options in cardiovascular medicine | Q27714743 |
P1476 | title | Cardiac stem cell therapy for cardiac repair | |
P478 | volume | 16 |
Q38344723 | Allogeneic cardiac stem cell administration for acute myocardial infarction |
Q38499161 | Arrhythmia in stem cell transplantation |
Q50000036 | Bone marrow mesenchymal stem cell-derived exosomal miR-21 protects C-kit+ cardiac stem cells from oxidative injury through the PTEN/PI3K/Akt axis. |
Q58767602 | Bradykinin-mediated Ca signalling regulates cell growth and mobility in human cardiac c-Kit progenitor cells |
Q41813361 | C-Kit Promotes Growth and Migration of Human Cardiac Progenitor Cells via the PI3K-AKT and MEK-ERK Pathways |
Q57165494 | Cardiac ageing: extrinsic and intrinsic factors in cellular renewal and senescence |
Q59326801 | Cardiac cell–integrated microneedle patch for treating myocardial infarction |
Q38652827 | Decline in cellular function of aged mouse c-kit+ cardiac progenitor cells. |
Q35509900 | Effect of aging on human mesenchymal stem cell therapy in ischemic cardiomyopathy patients |
Q38559308 | Evolving targeted therapies for right ventricular failure |
Q58796976 | Exosomes Derived from miR-214-Enriched Bone Marrow-Derived Mesenchymal Stem Cells Regulate Oxidative Damage in Cardiac Stem Cells by Targeting CaMKII |
Q36728608 | Fibrous scaffolds for building hearts and heart parts |
Q37120596 | Finding Expandable Induced Cardiovascular Progenitor Cells |
Q35875613 | Glutamine Regulates Cardiac Progenitor Cell Metabolism and Proliferation |
Q38796986 | Hippo/Yap Signaling in Cardiac Development and Regeneration |
Q47144816 | Human Cardiac-Derived Stem/Progenitor Cells Fine-Tune Monocyte-Derived Descendants Activities toward Cardiac Repair |
Q57789124 | Human cardiac stem cells inhibit lymphocyte proliferation through paracrine mechanisms that correlate with indoleamine 2,3-dioxygenase induction and activity |
Q51485564 | In vitro expansion of human cardiac progenitor cells: exploring 'omics tools for characterization of cell-based allogeneic products. |
Q91256706 | Insights from molecular signature of in vivo cardiac c-Kit(+) cells following cardiac injury and β-catenin inhibition |
Q35125630 | Matrix metalloproteinase 9 secreted by hypoxia cardiac fibroblasts triggers cardiac stem cell migration in vitro |
Q30841694 | Non-invasive in vivo imaging of cardiac stem/progenitor cell biodistribution and retention after intracoronary and intramyocardial delivery in a swine model of chronic ischemia reperfusion injury |
Q37016190 | Position Paper of the European Society of Cardiology Working Group Cellular Biology of the Heart: cell-based therapies for myocardial repair and regeneration in ischemic heart disease and heart failure |
Q39069601 | Possible Muscle Repair in the Human Cardiovascular System |
Q36617382 | Preconditioning Human Cardiac Stem Cells with an HO-1 Inducer Exerts Beneficial Effects After Cell Transplantation in the Infarcted Murine Heart |
Q39838646 | Sphingosine 1-phosphate elicits RhoA-dependent proliferation and MRTF-A mediated gene induction in CPCs |
Q38535126 | The Clinical Status of Stem Cell Therapy for Ischemic Cardiomyopathy |
Q36326979 | Transcription factor-induced activation of cardiac gene expression in human c-kit+ cardiac progenitor cells |
Q37359807 | miR-21 Reduces Hydrogen Peroxide-Induced Apoptosis in c-kit+ Cardiac Stem Cells In Vitro through PTEN/PI3K/Akt Signaling. |
Q42135508 | miR-21 increases c-kit+ cardiac stem cell proliferation in vitro through PTEN/PI3K/Akt signaling |
Search more.